DK0475160T3 - Præparat til applikation af aktivstof i form af meget små dråber - Google Patents

Præparat til applikation af aktivstof i form af meget små dråber

Info

Publication number
DK0475160T3
DK0475160T3 DK91114163.8T DK91114163T DK0475160T3 DK 0475160 T3 DK0475160 T3 DK 0475160T3 DK 91114163 T DK91114163 T DK 91114163T DK 0475160 T3 DK0475160 T3 DK 0475160T3
Authority
DK
Denmark
Prior art keywords
preparation
active substance
application
small drops
substance
Prior art date
Application number
DK91114163.8T
Other languages
English (en)
Other versions
DK0475160T4 (da
Inventor
Gregor Cevc
Original Assignee
Gregor Cevc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0475160(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19914107153 external-priority patent/DE4107153A1/de
Priority claimed from DE19914107152 external-priority patent/DE4107152C2/de
Application filed by Gregor Cevc filed Critical Gregor Cevc
Application granted granted Critical
Publication of DK0475160T3 publication Critical patent/DK0475160T3/da
Publication of DK0475160T4 publication Critical patent/DK0475160T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91114163T 1990-08-24 1991-08-23 Præparat til aktivstofapplikation i smådråbeform DK0475160T4 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4026833 1990-08-24
DE4026834 1990-08-24
DE19914107153 DE4107153A1 (de) 1991-03-06 1991-03-06 Praeparat zur wirkstoffapplikation in kleinsttroepfchenform
DE19914107152 DE4107152C2 (de) 1991-03-06 1991-03-06 Präparate zur nichtinvasiven Verabreichung von Antidiabetica

Publications (2)

Publication Number Publication Date
DK0475160T3 true DK0475160T3 (da) 1996-07-08
DK0475160T4 DK0475160T4 (da) 2004-11-22

Family

ID=27435001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91114163T DK0475160T4 (da) 1990-08-24 1991-08-23 Præparat til aktivstofapplikation i smådråbeform

Country Status (9)

Country Link
US (1) US20070042030A1 (da)
EP (1) EP0475160B8 (da)
JP (1) JP3765579B2 (da)
AT (1) ATE134133T1 (da)
CA (1) CA2067754C (da)
DE (1) DE59107402D1 (da)
DK (1) DK0475160T4 (da)
ES (1) ES2085936T5 (da)
WO (1) WO1992003122A1 (da)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
ES2107668T3 (es) * 1992-07-08 1997-12-01 Dianorm G Maierhofer Gmbh Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
US6663885B1 (en) * 1993-03-15 2003-12-16 A. Natterman & Cie Gmbh Aqueous liposome system and a method for the preparation of such a liposome system
DE4308121A1 (de) * 1993-03-15 1994-09-22 Rhone Poulenc Rorer Gmbh Wäßriges Liposomensystem sowie Verfahren zur Herstellung eines derartigen Liposomensystems
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
JP3136352B2 (ja) * 1996-01-22 2001-02-19 参天製薬株式会社 角結膜疾患治療剤
US5910306A (en) * 1996-11-14 1999-06-08 The United States Of America As Represented By The Secretary Of The Army Transdermal delivery system for antigen
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
TW592713B (en) 1998-05-11 2004-06-21 Ciba Sc Holding Ag Use of nanodispersions in cosmetic end formulations
US7381423B2 (en) 1998-05-11 2008-06-03 Ciba Specialty Chemicals Corp. Use of nanodispersions in cosmetic end formulations
US6302863B1 (en) 1998-06-16 2001-10-16 Nikolai Tankovich Method for removal of lipids via a perfluorocarbon tumescent solution
CN1322129A (zh) * 1998-09-01 2001-11-14 伊迪亚股份公司 带电穿透剂通过屏障的电控转运
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
CN1192766C (zh) * 1998-10-23 2005-03-16 伊迪亚股份公司 开发、测试和使用用于改进的有效负载和可控制性解缔/缔合速度的大分子和复合聚集体的缔合物的方法
ES2226203T3 (es) * 1998-12-23 2005-03-16 Idea Ag Formulacion mejorada para aplicacion topica no invasiva.
DK1031347T3 (da) * 1999-01-27 2002-07-08 Idea Ag Transnasal transport/immunisering med meget tilpasselige bærere
ES2173678T3 (es) 1999-01-27 2002-10-16 Idea Ag Vacunacion no invasiva a traves de la piel.
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
WO2001035998A1 (en) * 1999-11-12 2001-05-25 Pharmaderm Laboratories, Ltd. Compositions for transdermal and transmucosal administration of therapeutic agents
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
AU2001248301A1 (en) * 2000-04-12 2001-10-23 Liplasome Pharma A/S Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin
US6451808B1 (en) * 2000-10-17 2002-09-17 Depomed, Inc. Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
IL139177A0 (en) * 2000-10-20 2001-11-25 S C Republic Dev S R L Sustained release drug delivery system
GB0028706D0 (en) * 2000-11-24 2001-01-10 Unilever Plc Cosmetic composition
US20020177626A1 (en) 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
EP1230917A1 (de) 2001-02-08 2002-08-14 Vectron Therapeutics AG Invasomen zur Therapie von Erkrankungen, ihre Herstellung und Verwendung
AU2003233396B2 (en) * 2002-03-13 2007-05-24 Thomas Skold Water-based delivery systems
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1551370B1 (en) * 2002-10-11 2007-12-19 Idea Ag Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
US20070042998A1 (en) * 2005-08-19 2007-02-22 Annica Karkkainen Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein
DE102006013623A1 (de) * 2005-11-23 2007-05-24 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Verminderung des verwertbaren Kaloriengehalts der Nahrung und zur therapeutischen Gewichtsabnahme. Insbesondere zur Anwendung bei Adipositas (Fettsucht)
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
CN101400354B (zh) * 2006-03-13 2014-10-22 株式会社·R-技术上野 水性组合物
KR20160033796A (ko) 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
WO2008140594A2 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
CA2671447A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
DE102007028360B4 (de) 2007-06-15 2016-04-14 Marcus Asam Wirkstoffkombination für kosmetische Zubereitungen
AU2010255391C1 (en) 2009-06-03 2016-10-27 Sequessome Technology Holdings Limited Formulations for the treatment of deep tissue pain
JP2013502436A (ja) 2009-08-21 2013-01-24 ターゲッティド デリバリー テクノロジーズ リミテッド 小胞状の製剤
JP5711125B2 (ja) * 2009-08-21 2015-04-30 アース製薬株式会社 薬剤を植物体に取り込ませる方法
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
US20120190609A1 (en) * 2010-08-30 2012-07-26 Martin Bader Method for producing a lipid particle, the lipid particle itself and its use
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
WO2013057208A1 (en) 2011-10-18 2013-04-25 Targeted Delivery Technologies Limited Compositions and methods for reducing the proliferation and viability of microbial agents
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
GB201208384D0 (en) 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, uses and methods
GB201208409D0 (en) 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, kits and uses
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9943816B2 (en) 2014-10-20 2018-04-17 Eastman Chemical Company Amphoteric ester sulfonates
US9381147B2 (en) * 2014-10-20 2016-07-05 Johnson & Johnson Consumer Inc. Compositions comprising zwitterionic ester ammonioalkanoates
US9533951B2 (en) 2014-10-20 2017-01-03 Eastman Chemical Company Heterocyclic amphoteric compounds
EP3247333B1 (en) 2015-01-20 2021-07-21 Tetraderm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
WO2017001617A1 (en) 2015-06-30 2017-01-05 Sequessome Technology Holdings Limited Blended formulations
US9993408B2 (en) 2015-09-17 2018-06-12 Johnson & Johnson Consumer Inc. Compositions comprising zwitterionic alkyl-alkanoylamides and/or alkyl alkanoates
US11414380B2 (en) 2015-09-17 2022-08-16 Eastman Chemical Company Amphoteric compounds
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
US20210113595A1 (en) * 2018-04-30 2021-04-22 Purdue Research Foundation Liposomal nano formulation of combinational antibiotics and the uses thereof
CN111904932B (zh) * 2019-05-08 2023-06-20 北京德立福瑞医药科技有限公司 一种含有糖皮质激素的胶束制剂及其制备方法
DE202019002134U1 (de) 2019-05-16 2019-06-06 Penta Phi Eg Liposomales Glutathion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
EP0102324A3 (de) * 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
GB8321913D0 (en) * 1983-08-15 1983-09-14 Acacia Chem Ltd Spray method
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
US5104661A (en) * 1989-08-14 1992-04-14 Technology Unlimited, Inc. Reverse loading of liposomes

Also Published As

Publication number Publication date
EP0475160A1 (de) 1992-03-18
JPH05502042A (ja) 1993-04-15
US20070042030A1 (en) 2007-02-22
ES2085936T5 (es) 2005-03-01
CA2067754A1 (en) 1992-02-25
WO1992003122A1 (de) 1992-03-05
DK0475160T4 (da) 2004-11-22
JP3765579B2 (ja) 2006-04-12
ATE134133T1 (de) 1996-02-15
CA2067754C (en) 2002-06-04
EP0475160B1 (de) 1996-02-14
DE59107402D1 (de) 1996-03-28
EP0475160B2 (de) 2004-07-14
ES2085936T3 (es) 1996-06-16
EP0475160B8 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
DK0475160T3 (da) Præparat til applikation af aktivstof i form af meget små dråber
DE3867866D1 (de) Liposomzubereitung und ihre herstellung.
DE69637061D1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
DE69524448D1 (de) Fusogene liposomen
ES2089011T3 (es) Excipiente lipidico de administracion nasal y aplicacion topica.
FI891774A0 (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
NO870560L (no) Nytt farmasoeytisk preparat.
DE3678587D1 (de) Herstellungsverfahren fuer liposome, behaelter zu dessen durchfuehrung sowie zusammensetzung zur verwendung bei der herstellung von liposommaterial.
ATE199646T1 (de) Halbfeste arzneimittel sowie verfahren zu deren herstellung
KR910021361A (ko) 항궤양 물질
ATE8880T1 (de) Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR910021238A (ko) 켈로이드 치료제
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
DE3865201D1 (de) Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.
ATE179070T1 (de) Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
EP0362731A3 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten
AR003920A1 (es) Metodo para producir complejos droga/lipidos que tienen cargas positivas en exceso con respecto a la droga y los complejos droga/lipidos obtenidos condicho metodo y metodo para dispensar una droga a una persona.
Marder et al. Low dose pharmacotherapy and skills training
JPS56123919A (en) Remedy and preventive for diabetes
DK1683518T3 (da) Farmaceutisk formulering af formoterol og propylenglykol
Buri Transnasal systemic medications. Fundamentals, developmental concepts and biomedical assessments: Yie W. Chien (ed.), Elsevier, Amsterdam, 1985, 226 pages, $53.75/Dfl. 145.00
IT9020946A0 (it) Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva
SU1630045A1 (ru) Способ получения линимента алоэ "алором"
HUT56487A (en) Process for producing solid pharmaceutical composition decomposing in stomach